Literature DB >> 7915325

Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.

M M Teeter1, M Froimowitz, B Stec, C J DuRand.   

Abstract

We present the first model of dopamine D2 receptor transmembrane helices constructed directly from the bacteriorhodopsin (bR) coordinates derived from two-dimensional electron diffraction experiments. We have tested this model by its ability to accommodate rigid agonist and semirigid antagonist molecules which were docked into the putative binding pocket with stabilizing interactions. The model is consistent with structure-activity relationships of agonists and antagonists that interact with the receptor. It also illuminates data on a Na+ site for regulation of receptor function. The plausibility of the model is increased by its consistency with many mutagenesis studies on G protein-coupled receptors. Further, this model provides a basis to suggest testable molecular mechanisms for changes in the D2 conformational states for high- and low-affinity binding and signal transduction. Changes in the conformational state of the receptor are hypothesized to be due partly to movement of helix 7. In contrast to the model presented here, other published models were built using ideal helical structures or following the sense of the bacteriorhodopsin structure rather than the actual available coordinates. The presented model for the dopamine G protein-coupled receptor can be reconciled with the recent rhodopsin projection structure (Schertler, G. F. X.; Villa, C.; Henderson, R. Projection Structure of Rhodopsin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915325     DOI: 10.1021/jm00044a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.

Authors:  H Hausmann; A Richters; H J Kreienkamp; W Meyerhof; H Mattes; K Lederis; H Zwiers; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

Review 3.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

4.  Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.

Authors:  S Moro; C Hoffmann; K A Jacobson
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

5.  5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.

Authors:  Tony Ngo; Timothy J Nicholas; Junli Chen; Angela M Finch; Renate Griffith
Journal:  J Comput Aided Mol Des       Date:  2013-04-27       Impact factor: 3.686

6.  Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models.

Authors:  T G Metzger; M G Paterlini; P S Portoghese; D M Ferguson
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.

Authors:  Chiara Custodi; Roberto Nuti; Tudor I Oprea; Antonio Macchiarulo
Journal:  J Mol Graph Model       Date:  2012-07-20       Impact factor: 2.518

8.  Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor.

Authors:  Zhan-Guo Gao; Soo-Kyung Kim; Ariel S Gross; Aishe Chen; Joshua B Blaustein; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

9.  The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists.

Authors:  M Yashar S Kalani; Nagarajan Vaidehi; Spencer E Hall; Rene J Trabanino; Peter L Freddolino; Maziyar A Kalani; Wely B Floriano; Victor Wai Tak Kam; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

10.  Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.

Authors:  Vladimir Sukalovic; Vukic Soskic; Milan Sencanski; Deana Andric; Sladjana Kostic-Rajacic
Journal:  J Mol Model       Date:  2013-01-09       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.